| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |